Readystate Asset Management LP Cytom X Therapeutics, Inc. Transaction History
Readystate Asset Management LP
- $3.27 Trillion
- Q2 2025
A detailed history of Readystate Asset Management LP transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Readystate Asset Management LP holds 844,643 shares of CTMX stock, worth $1.57 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
844,643Holding current value
$1.57 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding CTMX
# of Institutions
69Shares Held
54.8MCall Options Held
8.9KPut Options Held
47.9K-
Vanguard Group Inc Valley Forge, PA9.38MShares$17.4 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA6.72MShares$12.5 Million0.28% of portfolio
-
Franklin Resources Inc San Mateo, CA5.77MShares$10.7 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$9.72 Million0.15% of portfolio
-
Prosight Management, LP Dallas, TX3.93MShares$7.31 Million0.9% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $123M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...